Provided are 5-membered heterocycle-based p38 kinase inhibitors. Further provided are pyrazole and imidazole-based p38 kinase, including p38α, and p38β kinase, inhibitors. Pharmaceutical compositions containing the compounds are also provided. Methods of use of the compounds and compositions are also provided, including methods of treatment, prevention, or amelioration of one or more symptoms of p38 kinase mediated diseases and disorders, including, but not limited to, inflammatory diseases and disorders.
Benzamide derivative with anticancer activity and preparation method and use thereof
申请人:Bai Hua
公开号:US08946478B2
公开(公告)日:2015-02-03
Provided are a benzamide derivative as shown in formula (I) or a pharmaceutically acceptable salt thereof, and the preparation method and use thereof for preparing a medicine for treating cancer, wherein the group definitions of formula (I) are as set out in the description.
Biphenylcyclopropylamides as p-38 Kinase inhibitors
申请人:Novartis AG
公开号:EP1990338B1
公开(公告)日:2010-09-22
US8946478B2
申请人:——
公开号:US8946478B2
公开(公告)日:2015-02-03
BENZAMIDE DERIVATIVE WITH ANTICANCER ACTIVITY AND PREPARATION METHOD AND USE THEREOF
申请人:Bai Hua
公开号:US20130225810A1
公开(公告)日:2013-08-29
Provided are a benzamide derivative as shown in formula (I) or a pharmaceutically acceptable salt thereof, and the preparation method and use thereof for preparing a medicine for treating cancer, wherein the group definitions of formula (I) are as set out in the description.